A recently approved immunization drug is helping to limit the severity of a respiratory disease that afflicts young children ...

RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...

There has been a "dramatic" decrease in cases of RSV among babies due to a new vaccine but flu is rising and expected to peak after Christmas, the interim chief medical officer said. Usually one in ...

Respiratory syncytial virus (RSV) is an infectious respiratory disease that can look and sound a lot like a cold, with ...

IDWeek 2024 was held at the Los Angeles Convention Center in Downtown Los Angeles, CA, USA, from 16–19 October. Phoebe Hall ...

AstraZeneca and Sanofi now have the data they need in hand to press ahead with regulatory filings next year for nirsevimab, an antibody designed to prevent respiratory syncytial virus (RSV ...

The preventive medicine Beyfortus (Nirsevimab) against the Respiratory Syncytial Virus (RSV) for newborns is expected to arrive in Austria in the coming days.

The panel also said Beyfortus (nirsevimab) could be an option for some older babies at increased risk of severe illness caused by RSV as it recommended that the shot be used in the US Vaccines for ...

SummaryState warns of rising COVID threat, surge in Whooping Cough cases The Illinois Department of Public Health is ...